期刊文献+

磷酸二酯酶(Ⅴ)抑制剂伐地那非的合成 被引量:4

The synthesis of a phosphodiesterase(Ⅴ) inhibitor Vardenafil
下载PDF
导出
摘要 报道了以2乙氧基苯腈、DL丙氨酸为原料合成出一种名为伐地那非(Vardenafil)的选择性磷酸二酯酶(Ⅴ)抑制剂。对决定反应总收率的关键步骤———两步成环法进行了讨论,首次分离出了该方法的中间体4,对所有反应条件进行了优化。目标产物及各有机中间体的1HNMR均与文献一致。 A selective phosphodiesterase (Ⅴ) inhibitor called Vardenafil was synthesized by using 2-ethoxybenzonitrile and DL-alanine as the raw materials. The two ring-closing reaction which is the decisive procedure of the whole synthesis was discussed and a new intermediate 4 was first separated. All the reaction conditions were optimized and all NMR spectrum data of the target molecule and intermediates are the same as those of reported.
出处 《化学试剂》 CAS CSCD 北大核心 2006年第5期287-289,共3页 Chemical Reagents
关键词 磷酸二酯酶(Ⅴ)(PDE5) 抑制剂 伐地那非 合成 phosphodiesterase (Ⅴ) (PDE5) inhibitors Vardenafil synthesis
  • 相关文献

参考文献7

  • 1PETER J D.Synthesis of commercial phosphodiesterase (Ⅴ)inhibitors[J].Organic Process Research & Development,2005,9(1):88-97. 被引量:1
  • 2WILKENS H.Effect of inhaled iloprost plus sildenafil inpatients with primary pulmonary hypertension[J].Circulation,2001,10(4):1218-1222. 被引量:1
  • 3MASAHIRO T,YOSHIMURA I,TAKIZAWA K,et al.Surface active N-acylglutamate:preparation of long chain N-acylglutamic acid[J].Journal of the American Oil Chemists' Society,1972,49(3):157-161. 被引量:1
  • 4CHARLES I,DAVID W S,HARTLEY D,et al.Bicyclic heterocyles with nitrogen at the ring junction[J].J.Chem.Soc.,Perkin Trans.1,1980,(5):1139-1146. 被引量:1
  • 5ULRICH N,MAZEN E S.2-Phenyl substituted imidazotriazinones as phosphodiesterase inhibitors:US,6362178(B1)[P].2002-03-26. 被引量:1
  • 6段行信编..实用精细有机合成手册[M].北京:化学工业出版社,2000:523.
  • 7GOETZ B,MARTIN H,CHRISTOPH K,et al.Characterization of alkoxycarbonyl radicals by step-scan time-resolved infrared spectroscope[J].Eur.J.Org.Chem.,2001,(3),545-552. 被引量:1

同被引文献37

  • 1黄喜茹,王淑月,申朋,马鹂,高洁.计算机程序-多波长直线回归法测定复方氯麻滴鼻液中三组分的含量[J].化学试剂,2007,29(7):407-409. 被引量:2
  • 2Harming H, Niewohner U, Sehenke T, et al. Imidazo [5,1-f] [1,2,4] triazin-4(3H)-ones,a new class of potent PDE-5 inhibitors [ J ]. Bioorg Med Chem Lett, 2002,12:865 -868. 被引量:1
  • 3Peter J D. Synthesis of commercial phosphodiesterase ( Ⅴ ) inhibitors [ J ]. Org Process Res Dev, 2005,9 (1) :88 -97. 被引量:1
  • 4Nowakowski M, Vetter A. Method for the production of 2-( 2-ethoxyphenyl ) -substituted imidazotriazinones [P]. US 20 040 097 505,2004. 被引量:1
  • 5Meelvaln S M, Nelson J W. The preparation of orthoesters [ J ]. J Am Chem Soc, 1942,64 : 1827. 被引量:1
  • 6Thu-Cuc N T, Buu-Hoi N P, Xuong N D. Potential antiftmgal benzhydrazides [ J ]. J Mecl Pharm Chem, 1961,3:361 - 367. 被引量:1
  • 7Shriner R L, Neumann F W. The chemistry of the amidines [ J]. Chem Bey, 1944,35(3) :351 - 425. 被引量:1
  • 8Mclennan D J, Pross A, The mechanism for nucleophilic substitution of α-carbonyl derivatives, application of the valence-bond configuration mixing model[J]. J Chem Soc Pekin Trans Ⅱ,1984,6:981 -984. 被引量:1
  • 9Cartor AJ, Ballard SA, Naylor AM. Effect of the selective phosphordiesterase type 5 inhibitor sildenafil on erectile function in the anesthetized dog [J]. J Urol, 1998, 160(1): 242-246. 被引量:1
  • 10Namachivayam P, Thei|en U, Butt WW, et al. Sildenafil prevents rebound pulmonary hypertension after withdrawal of nitricoxide in children [J]. Am J Respir Crit Care Med, 2006, 174 (9) : 1042-1047. 被引量:1

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部